UNITED24 - Make a charitable donation in support of Ukraine!

Homeland Security

H7N9 flu vaccine set for mass production in June: Taiwanese firm

ROC Central News Agency

2014/02/20 21:22:28

Taipei, Feb. 20 (CNA) A Taiwan-made vaccine for the H7N9 strain of avian flu is expected to begin mass production in June this year after completing human trials, Taichung-based Adimmune Corp. said Thursday.

Adimmune, the only human vaccine producer in Taiwan, said it has completed animal trials and will begin a second phase of human trials for its H7N9 vaccine in March.

One of the world's first GMP vaccine manufacturers to engage in research and development of a vaccine for H7N9, the company said it will be able to produce 3 million doses of the vaccine per month once mass-production has begun.

Even if the Taiwan government does not purchase the vaccines, Adimmune said it will continue with development so that it will be ready to start mass-producing them at any time should there be a need.

According to the Ministry of Health and Welfare, a total of 353 confirmed H7N9 cases were reported in China and Hong Kong since March 2013, including two exported to Taiwan. There were 78 fatalities in the year.

(By Lung Jui-yun and Jeffrey Wu)
ENDITEM/WH



NEWSLETTER
Join the GlobalSecurity.org mailing list